Kewaunee Scientific (KEQU)
Designs, manufactures, and installs laboratory furniture, infrastructure, and biosafety equipment.
$34.10
After hours−0.09 (−0.28%)
At close$34.20(−1.37%)
In millions of USD, except per-share figures
| In millions | Q2 FY24Oct 2023 | Q3 FY24Jan 2024 | Q4 FY24Apr 2024 | Q1 FY25Jul 2024 | Q2 FY25Oct 2024 | Q3 FY25Jan 2025 | Q4 FY25Apr 2025 | Q1 FY26Jul 2025 | Q2 FY26Oct 2025 | Q3 FY26Jan 2026 | Q4 FY26Apr 2026 | Q1 FY27Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50 | 47 | 57 | 48 | 48 | 67 | 77 | 71 | 70 | 69 | 71 | 66 |
| Cost of revenue | 37 | 35 | 42 | 36 | 34 | 49 | 53 | 50 | 50 | 51 | 50 | 47 |
| Gross profit | 13 | 12 | 15 | 12 | 14 | 18 | 24 | 21 | 20 | 19 | 21 | 20 |
| 8 | 8 | 9 | 10 | 10 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | |
| Research & development | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| 0 | 8 | 9 | 10 | 10 | 16 | 16 | 16 | 16 | 0 | 16 | 0 | |
| Selling & marketing | 0 | 8 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 |
| General & administrative | 0 | 0 | 4 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 15 | 0 |
| Other expenses | 0 | 8 | 0 | 10 | 10 | 16 | −1 | 16 | 16 | 16 | −1 | 16 |
| Operating income | 5 | 4 | 6 | 3 | 4 | 2 | 9 | 5 | 4 | 3 | 5 | 3 |
| 0 | 0 | −4 | 0 | −1 | −1 | −1 | −1 | −1 | −1 | 0 | −1 | |
| Interest expense | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 5 | 4 | 1 | 2 | 4 | 1 | 7 | 4 | 3 | 2 | 5 | 3 |
| Income tax expense | 2 | 1 | −10 | 0 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 1 |
| Net income from continuing operations | 3 | 3 | 11 | 2 | 3 | 1 | 5 | 3 | 3 | 1 | 4 | 2 |
| Net income | 3 | 3 | 11 | 2 | 3 | 1 | 5 | 3 | 2 | 1 | 3 | 2 |
| EPS, basic | $0.94 | $0.87 | $3.86 | $0.77 | $1.05 | $0.47 | $1.70 | $1.08 | $0.85 | $0.24 | $1.18 | $0.59 |
| EPS, diluted | $0.93 | $0.85 | $3.71 | $0.74 | $1.01 | $0.45 | $1.63 | $1.04 | $0.82 | $0.23 | $1.13 | $0.58 |
| Weighted average shares, basic | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Weighted average shares, diluted | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBITDA | 5 | 5 | 2 | 4 | 5 | 4 | 10 | 7 | 6 | 4 | 7 | 5 |
| Depreciation & amortization | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| EBIT | 5 | 4 | 2 | 3 | 4 | 2 | 8 | 5 | 5 | 3 | 5 | 3 |
